chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had first shot 01Apr2021 and then I had Covid am diagnosed with Covid 05Apr2021; This is a spontaneous report received from a contactable consumer (patient) A 75-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: ERE734 and Expiration date was unknown), dose 1 via an unspecified route of administration on 01Apr2021 (age at the time 75-year-old) as 1st dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 05Apr2021, the patient had tested for COVID-19, but never had any problem. It happened a couple of month 60 days since. She wants to know that she still needs to receive her second dose and wants to know how to proceed. The patient wanted the timing of the 2nd shot. There was a product complaint. The patient underwent lab tests and procedures which included COVID-19 SARS cov-2 test was positive on 05Apr2021 and unspecified lab data also performed. The outcome of event was unknown.  Information on Lot/Batch number was available. Additional information has been requested
EE called hotline stating he received a call from Urgent Care that he has a POSITIVE covid test result from 5/28/21. He was called from Urgent Care providers. EE symptomatic. EE went on his own on 5/28 to Urgent Care and was swabbed. EE was not swabbed through EH hotline. Results not available on Epic. EE called dls and Urgent Care for a copy of his results, but they have not given it to him. Instructed EE to email a copy of positive covid results to Employee Health and covid surveillance. EE to update manager. Spoke with nurse at Urgent Care who verified that EE is Covid Positive. States she will email the results. EE states he is fully vaccinated, last dose on 1/13/21. EE states he is not a part of the SARS study, but he would like to do the antibody blood test. EE to do antibody testing after quarantined. Orders placed and instructions given to EE to obtain blood test at DLS. Instructed EE he will need to isolate & quarantine at least 10 days and/or until symptom free. EE to call hotline when he is released from DOH and to update us on his symptoms.   HISTORY 5/28/21:  EE stated he woke up with sore throat, feeling lethargic, fever, and cold sweats today 5/28/21.  EE stated he went to Urgent Care on his own today, swabbed for strep which was negative and swabbed for covid; awaing covid test results.  EE instructed to quarantine while results pending; if negative no longer needs to quarantine.  EE instructed to call the hotline with his results.  EE informed when he calls hotline, he will be given further guidance for clearance and will be asked to email the results to employee health.  EE informed to keep his manager updated.
SWOLLEN ARM; WARM  TO TOUCH; REDNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029 and expiry: 25-MAY-2021) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-MAR-2021, the subject experienced swollen arm. On 14-MAR-2021, the subject experienced skin warm. On 14-MAR-2021, the subject experienced injection site redness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the swollen arm, injection site redness and skin warm was not reported. This report was non-serious.
Itchy; It developed rash and beginning to extend the lower part of the injection site; injection site soreness; injection site redness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE RASH (It developed rash and beginning to extend the lower part of the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included MONASCUS PURPUREUS, NICOTINAMIDE, PHYTOSTEROLS NOS (RED YEAST RICE WITH PLANT STEROLS) and ATORVASTATIN CALCIUM (LIPITOR) for Hyperlipidemia, CENTRUM SILVER +50 for Immunodeficiency.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness). On 19-Jan-2021, the patient experienced PRURITUS (Itchy) and VACCINATION SITE RASH (It developed rash and beginning to extend the lower part of the injection site). At the time of the report, PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE RASH (It developed rash and beginning to extend the lower part of the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Benadryl cream.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Narrative:  An 85yo male with PMH of DM, Hyperlipidemia, CAD, A-fib, Cardiac Pace maker and overweight He received Pfizer Covid - 19 vaccine per policy and protocol First dose January 13, 2021 and the second dose on February 3, 2021 without complication No ADE was reported The system shows this patient passed away on 02/16/21
A parent reported that her daughter, who was now in her 20's, received as a child (age not specified) a tetanus toxoid vaccine (manufacturer not specified, lot number not provided). Following vaccination the patient had experienced high pitched screaming, seizure, and sensation of feeling cold. The parent stated that the events lasted 6 weeks. The outcome was not reported. The parent declined to provided any further information. Documents held by sender: None.
Dizziness Narrative:  5 minutes after received doses Dr was present vitals b/p 79/53 p 53 oxy 96%, Vs x4, no intervention needed last Vs prior to released 108/72 p 67 oxy 98.  Other Relevant History:
Pressure on head, Fog head; Pressure on head, Fog head; Dizzy tiny bit; Bruise on left arm, where shot was; Twitching in the left eyelid, eyebrow; Sore arm, were shot was, left; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 47-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: ER8737) via an unspecified route of administration, administered in Arm Left on 03Apr2021 10:50 (age at vaccination 47-years-old) as dose 1, single for COVID-19 immunization. Medical history included ongoing seasonal allergy. The patient's concomitant medication: everything she took was over the counter. No investigation assessment was performed. No additional vaccines were administered. On 03Apr2021, the patient experienced a sore left arm at the shot site. On 04Apr2021, the patient experienced twitching in the left eyelid, eyebrow. It lasted all day long. For 4 days in a row it was noticeable. Then it went away, but came back. It was not as strong, not as noticeable, not continuous but frequent. She could still feel it even today she had it. She had it now for 12 days. On 05Apr2021, the patient had bruise on left arm, where shot site was. She confirmed the bruise was not there anymore but did not know when it went away. On an unspecified date, she felt pressure on the head, fog head. She felt dizzy tiny bit. Dizzy over a week even a couple of days ago. She stated she did have seasonal allergies so was unsure if that was related. No emergency room and physician office visit. The patient underwent lab tests and procedures on an unspecified date which included blood test and physical examination and results were normal. The outcome of the event bruise on left arm, where shot site was unknown. The outcome of the event twitching in the left eyelid, eyebrow, pressure on head, fog head and dizzy tiny bit was recovering. The outcome of the event sore arm, were shot was, left was recovered on 05Apr2021.  No follow-up attempts are needed. No further information is expected.
Information has been received from a 60 year old female patient with drug reactions/allergies to "PERCOCET" and a history of tendon injury in approximately 1997 ("about 15 years ago"), who on 08-MAY-2012 was vaccinated with ZOSTAVAX (Merck) (dose and lot number not reported). Concomitant therapy included metoprolol, amlodipine, vitamin B12 and low dose aspirin. On approximately 11-MAY-2012 ("3-4 days after receiving ZOSTAVAX (Merck)") the patient had joint pain felt similar to the tendon injury she had several years ago. It was in the same spot in her right thumb and wrist going up to her forearm. The pain lasted for about 2-3 days, and the switched to her left hand. Treatment was given for an AE: 600mg MOTRIN, and ice. At the time of the report the outcome of the pain switched to left hand of the patient was not recovered. The patient did not seek medical attention. No laboratory diagnostic studies were performed. Follow up information was received from the physician concerning a 60 year old female patient with no illness at the time of vaccination and no previous adverse events following prior vaccination. On 08-MAY-2012, at 12 PM, the patient was vaccinated with a 1st dose of ZOSTAVAX subcutaneously in the left arm by a nurse (name unspecified). Lot number was reported as 671142/1268AA. The patient was vaccinated at a private doctor's office/hospital. Address of the facility where the patient was vaccinated was updated. On 09-MAY-2012 at 8 AM, the patient experienced right arm pain/numb (3 days) and left arm pain (3 days) (previously reported as 13-MAY-2012). One week later, on approximately 16-MAY-2012, the patient recovered. The patient did not seek medical attention. Causality was unknown for all the events. Additional information is not expected.
received the vaccine , by 3 hours later the area was swollen 'like a large goose egg size' and was painful, used an ice pack and Tylenol 100 mg plus Benadryl 25 mg one dose and again the next day. 9/12 the next day the arm was still swollen and warm to the touch. The area increased in redness and size as well as very tender. Each day after has slowly resolved.
Pt c/o uncomfortable, numbing/tingling pain, 5/10 scale, to the anterior chest wall, (L) mid-clavicular line, 2-3 intercostal space. Pea-sized, soft, moveable nodule, noted, tender to touch. Also c/o numbness to the injection site, (L) deltoid.
was diagnosed with COVID-19 after being fully vaccinated; was diagnosed with COVID-19 after being fully vaccinated; This is a spontaneous report from a non-contactable consumer. A 79-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Lot number was not reported) as dose 1, single and on an unspecified date (Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. There is unknown whether the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient on 04Aug2021 was diagnosed with covid-19 via SARS-COV-2 test (nasal swab) after being fully vaccinated. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache, Myalgia, Fever, chills Narrative:   Other Relevant History:
This spontaneous report has been received from a healthcare worker referring to unspecified number of patients. Concurrent condition and medical history were not reported. On unknown dates the patients were vaccinated with M-M-R II (dose, frequency and route not reported, lot# reported as K002136, expired date: 10-FEB-2015; K011168, expired date: 12-AUG-2016). No adverse event were reported. This is one of the several reports from the same reporter. Lot # K002136 and K011168 are invalid lot number for M-M-R II. Additional information has been requested.
Approx 15 minutes after receiving vaccine patient became dizziness with abdominal pain. Blood pressure was 200/100 and pulse oximeter 80's. Pt was not having any swelling of the airway or difficulty breathing.
LOST SENSE OF SMELL; LOST SENSE OF TASTE; HEADACHE; NAUSEA; NOT FEELING WELL; This spontaneous report received from a patient concerned a 43 year old male. The patient's height, and weight were not reported. The patient's past medical history included: back surgery, and spinal fusion, and concurrent conditions included: back problems, alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient had no known allergies. The patient did not have any drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1816022, expiry: UNKNOWN) dose was not reported, administered on 25-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-MAY-2021, the patient experienced not feeling well, and nausea. On 27-MAY-2021, the patient experienced lost sense of smell, lost sense of taste, and headache. Laboratory data (dates unspecified) included: Computerised tomogram (NR: not provided) unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from not feeling well, and nausea on 27-MAY-2021, and headache on 30-MAY-2021, and had not recovered from lost sense of smell, and lost sense of taste. This report was non-serious.
Patient received the shingles vaccine ZOSTAVAX, on 9-14-16 by RPh. On 9-28-16 patient called saying she now has shingles.
sleepiness; weakness; malaise; brain fog; inability to rise from her bed the morning; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog) and DYSSTASIA (inability to rise from her bed the morning) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart valve replacement (significant for valve replacement) in May 2020 and Pacemaker insertion (cardiac) in May 2020.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog), DYSSTASIA (inability to rise from her bed the morning) and FATIGUE (Fatigue). On 24-Feb-2021, SOMNOLENCE (sleepiness), ASTHENIA (weakness), MALAISE (malaise), FEELING ABNORMAL (brain fog), DYSSTASIA (inability to rise from her bed the morning) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Both medical history were added.
Resident received 3 doses of the Pfizer vaccine. No adverse side effects at this time. Epidemiologist, stated to report extra dose given.
Patient said she experienced chills, fever, nausea, and headache about 5-6 days after first dose, but she recovered. However, she reports feeling "tired all the time" and chills around 7 pm every other night for the last couple of weeks, as well as a headache and nausea off and on. She said she didn't experience these symptoms before the vaccine.
Pt states she woke up day after getting vaccine and noted it was very tender and reddened. Pt states it just seemed to get bigger and down around arm. Reddened area noted a site that measures 50mm x 65mm. Instructed to use ice a couple times a day and to take Ibuprofen for discomfort.
Fever 1 degree F. Running nose . Sore throat. Sick for three hours
Injection site pain; injection site redness; injection site swelling; mild fatigue; dose_received: 3; product use for unapproved combination; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 49 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 17Dec2021 10:45 (Lot number: FE3594) at the age of 49 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine inact split 4v (FLUARIX QUADRIVALENT), administered in arm right, administration date 17Dec2021 (Batch/Lot number: unknown) as dose 1, 0.5 ml single for immunisation. Relevant medical history included: "known_allergies:latex" (unspecified if ongoing), notes: known allergies: latex. Concomitant medication(s) included: SPIRONOLACTONE; LEVOTHYROXINE; ZYTREC; TYLENOL. Past drug history included: Wellbutrin, reaction(s): "known allergies: Wellbutrin", notes: known allergies: Wellbutrin; Benadryl, reaction(s): "known allergies: Benadryl", notes: known allergies: Benadryl. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0187, Location of injection: Left Arm, Vaccine Administration Time: 06:00 PM), administration date: 24May2021, when the patient was 49 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0176, Location of injection: Left Arm, Vaccine Administration Time: 04:00 PM), administration date: 03May2021, when the patient was 49 years old, for COVID-19 Immunization.  The following information was reported: IMMUNISATION (non-serious) with onset 17Dec2021 10:45, outcome "unknown", described as "dose_received: 3"; VACCINATION SITE PAIN (non-serious) with onset 18Dec2021 00:30, outcome "recovering", described as "Injection site pain"; VACCINATION SITE ERYTHEMA (non-serious) with onset 18Dec2021 00:30, outcome "recovering", described as "injection site redness"; VACCINATION SITE SWELLING (non-serious) with onset 18Dec2021 00:30, outcome "recovering", described as "injection site swelling"; FATIGUE (non-serious) with onset 18Dec2021 00:30, outcome "recovering", described as "mild fatigue"; PRODUCT USE ISSUE (non-serious) with onset 17Dec2021, outcome "unknown", described as "product use for unapproved combination". Therapeutic measures were not taken as a result of vaccination site pain, vaccination site erythema, vaccination site swelling, fatigue.  Additional information: if other vaccine in four weeks: No if covid prior vaccination: No if covid tested post vaccination: No  No follow-up attempts are possible. No information is required.
TASTE OF MEDAL IN MOUTH AT TIME OF VACCINE FELT FLUID OF SHOT ENTERING MY ARM CHILLS FOR 6 HOURS , NO FEVER NUERLOGICAL SENSAATION IN MY ARMS AND FINGER TIPS THAT CONTINUE SINCE THE VACCINE WAS GIVEN THAT COMES AND GOES. iTS AN ANORING SENSATION MORE THEN PAINFUL.
01/22: palpitations, felt like my heart was skipping beats then would come back with a hard pound. Shortness of breath during episodes, dizziness, fatigue, loss of energy. Continued to get worse with each passing month. Pulse ox revealed my heart rate was as low as 26 bpm and regularly stayed around 35-45 bpm, even when active. By 09/22 it was occurring every day, all day causing extreme dizziness, fatigue, loss of energy, shortness of breath, lack of motivation. Frequent episodes of hot flashes co-occuring with dizziness, numbness & tingling in upper body, feeling faint, blurry vision, sever shortness of breath, feeling like my heart was skipping several beats and then would pound hard which felt like getting the wind knocked out me each time it did that. Symptoms still occur to present day with no relief or decline.
headache, slight sore throat, productive cough, chills, loss of smell, sinus congestion, post nasal drainage, chest congestion, sneezing, ear fullness. starting 10/28/21
"The patient is a 79 y.o. female who presented with SOA.  She has had increased dyspnea and fatigue for the past few days.  Tested positive for COVID yesterday.  Has had subjective fevers at home.  Not eating or drinking much.  No chest pain.  On 2L NC here, no home O2."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Acute hypoxemic respiratory failure due to COVID-19 Description of the Problem/Progression:  Plan: o Pneumonia due to Covid 19 virus with acute respiratory failure with hypoxia. Improving on current treatment. Completed Remdesivir D5/5 and transitioned IV Decadron to PO. Nebs and inhalers as ordered. Continue to follow up daily inflammatory markers and d-dimer. Patient continues with hypoxia requiring 2 L of oxygen by nasal cannula. Wean off oxygen as tolerated. IV antibiotics empirically for possible bacterial pneumonia. Sputum culture ordered. Continue nebs and inhalers. Encourage incentive spirometry use and pronating. Continue supportive/symptomatic treatment and supplements as ordered per COVID protocol. Follow up daily lab. Follow up outpatient with PCP. Ambulatory care manager referral given. o Hypokalemia. Treated. Continue to monitor lab closely and treat as needed with IV/oral K replacement until normalized. o Oral thrush. Nystatin Swish and swallow. Chloraseptic.  o Hypertension. Controlled. Continue same treatment. Follow up daily labs.  o Paroxysmal atrial fibrillation. Continue to monitor on telemetry. Remains controlled. Continue home medications regimen including oral anticoagulation.
SEVERE ITCHINESS; NUMB ON RIGHT HAND PINKY; This spontaneous report received from a patient concerned a 68 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: acid reflux, and inflammation in right knee, and other pre-existing medical conditions included: No pregnancy. The patient reported she does not take any medications because of her kidneys. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total administered on APR-2021 for prophylactic vaccination (dose series 1). The batch number was not reported. The company is unable to perform follow up to request batch/lot number. On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced severe itchiness (dose series 1).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of severe itchiness was recovered (date not specified) (dose series 1). On 22-NOV-2021 afternoon, the patient received additional non-company suspect vaccine included: mrna 1273 (batch number: OL19E21A expiry: UNKNOWN, form of admin, and route of admin, were not reported) dose was not reported, administered on right arm for prophylactic vaccination (dose series 2).   On an unspecified date in NOV-2021, following vaccination with mrna 1273, the patient experienced recurrent itchiness and numb on her right hand pinky with no other symptoms (dose series 2). She reported numb on her right hand pinky had never happened before. She saw a nurse on an unspecified date and received no treatment for side effects. The action taken with mrna 1273, was not applicable.  The outcome of recurrent itchiness and numb on right hand pinky was not reported.   This report was non-serious.